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Abstract
Syria is currently experiencing the world’s largest humanitarian crisis since World War II, and access 
to medicines for emergency care, pain control, and palliative care remains shockingly restricted in the 
country. Addressing the dire need for improved access to medicines in Syria from an international law 
compliance and accountability perspective, this article highlights four complementary legal frameworks: 
international human rights law, international drug control law, international humanitarian law, and 
international criminal law. It arrives at two central conclusions. First, all four bodies of law hold clear 
potential in terms of regulatory—hence compliance—and accountability mechanisms for improving 
access to medicines in times of conflict, but they are too weak on their own account. Second, the 
potential for on-the-ground change lies in the mutual reinforcement of these four legal frameworks. This 
reinforcement, however, remains rhetorical and far from practical. Finally, within this complex picture 
of complementary international legal frameworks, the article proposes concrete recommendations for 
a more integrated and mutually reinforcing interpretation and implementation of these areas of law to 
foster better access to medicines in Syria and elsewhere. 
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Introduction
Syria is currently experiencing the world’s largest 
humanitarian crisis since World War II.1 Over the 
last seven years, the world has witnessed the in-
tentional and continuous targeting of the civilian 
population through bombings and the denial of ba-
sic necessities, including food, water, and medicine.2 
According to figures from the European Commis-
sion, there are currently an estimated 13.5 million 
people in need of humanitarian assistance inside 
Syria, including 4.9 million in difficult-to-reach or 
besieged areas and 6.1 million internally displaced.3 
The widespread disregard for human rights and 
humanitarian law has led to an “overwhelming” sit-
uation in which the long-term consequences in the 
area of health care are grave: a shortage of qualified 
medical personnel and medicines, the destruction 
and targeting of health infrastructure, and the in-
tentional blocking of humanitarian assistance.4
Former Special Rapporteur on the right to 
health Anand Grover noted in a 2013 report that 
“conflict affects health not only through direct 
violence, but also through the breakdown of so-
cial structures and health systems, and the lack of 
availability of underlying determinants of health.”5 
Specifically, access to medicine can be affected 
since both state and non-state armed groups deploy 
numerous physical barriers for victims (such as 
travel bans and check points) and for health care 
providers (such as prohibited access to localities) 
during times of conflict. 
This article addresses how four complemen- 
tary international legal frameworks could be mutu-
ally reinforced to improve (though not necessarily 
remedy) the situation in Syria concerning access to 
medicines. After first addressing the dire situation 
in Syria, the article examines the frameworks of 
international human rights law, international drug 
control law, international humanitarian law, and 
international criminal law. These legal frameworks 
each have their own areas of focus and attention. 
While some are primarily focused on state com-
pliance with norms and best practices, others are 
more concerned with ensuring accountability. And 
all are relevant to the topic of access to medicine in 
times of conflict. Although these areas of law are 
complementary, the situation in Syria shows more 
than ever before the clear limits of the law in real-
izing access to medicines in practice and ensuring 
state compliance and individual accountability for, 
in particular, state actors failing to do so. The legal 
frameworks are therefore separately, and even in 
conjunction, inadequate to resolve the situation 
on the ground. Yet there is much that can be done, 
including formulating a joint general comment, 
supporting ad hoc humanitarian assistance by 
promoting the use of simplified procedures, and 
ensuring greater emphasis on violations of eco-
nomic, social, and cultural rights violations—in 
particular right to health violations—within legal 
frameworks that offer some, albeit minimal, forms 
of individual criminal accountability. 
The situation in Syria
The conflict in Syria began in 2011, after govern-
ment forces could not quell peaceful protests of 
the arrest and subsequent torture of a group of 
teenage boys who, inspired by the Arab Spring, had 
spray-painted antigovernment slogans on the wall 
of their school. By 2015, the United Nations (UN) 
Secretary-General reported that “there is a com-
plete and utter absence of protection of civilians in 
the Syrian Arab Republic.”6 From the beginning of 
the conflict, government forces in particular have 
used extreme and illegal tactics against civilian 
populations, including barrel bombs, chemical 
weapons, and the deliberate deprivation of food, 
water, and health care.7 
According to a 2015 report on health care in 
Syria, “civilians as well as healthcare personnel, 
medical facilities, and ambulances are deliberate-
ly and routinely targeted as part of the military 
strategy of the Syrian Government.”8 Until at least 
August 2015, no food or other type of humanitarian 
relief item reached any besieged area through offi-
cial routes.9 Even today, humanitarian relief within 
Syria has been sporadic and repeatedly thwarted by 
both the government and non-state armed groups.10 
A 2017 report of the Independent International 
Commission of Inquiry on the Syrian Arab Repub-
lic states that
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[r]epeated bombardments of hospitals and clinics 
in areas controlled by armed groups destroy vital 
infrastructure and kill medical personnel. The 
number of remaining doctors, nurses, and first 
responders is now so grossly inadequate to meet the 
needs of the population that many injured civilians 
die due to lack of access to adequate medical care. In 
besieged areas, the lack of access to medical supplies, 
including anaesthetics, surgical equipment, and 
medication, makes it impossible for hospitals and 
clinics to provide even the bare minimum care to 
patients.11
Access to medical supplies and equipment has 
remained extremely restricted in some areas as a 
result of insecurity and access constraints imposed 
by parties to the conflict. In particular, Aleppo, 
Dar’a, Hama, Idlib, and, most recently, Ghouta 
have been badly affected.12 The inquiry commis-
sion notes in relation to Aleppo that “even prior 
to the siege, civilians in eastern Aleppo city lacked 
sufficient food, medication, and fuel.”13 While the 
situation for civilians in Syria is dire and unprec-
edented since World War II, the problem of access 
to medicine encountered in the Syrian conflict is 
all too familiar.14 As with other conflict situations, 
the main obstacles include physical barriers, polit-
ical barriers, and direct violence against medical 
personnel, all of which can severely affect access to 
health care facilities, goods, and services.15 
Prior to the conflict, Syria’s health care sys-
tem was comparable with the health care systems 
of other middle-income countries.16 Much of the 
health care system consisted of a government-run 
public scheme that provided mostly primary care 
services, with the private sector providing some 
of the advanced care services. The deteriorating 
security situation since 2012, leading to the em-
igration of qualified manpower and experts, has 
resulted in a shortage of medicine and access to 
medicine throughout Syria. In many parts of the 
country, the conflict has turned otherwise man-
ageable chronic diseases into unnecessary terminal 
conditions because of the unavailability of curative 
treatment and medicines.17 At the same time, ur-
gently needed pain control medicines and palliative 
care also depend on a sufficient health care system 
and infrastructure. The express targeting of civil-
ians through the deprivation of food, water, and 
medicines has had a devastating impact. Civilian 
casualties have long accounted for the largest group 
of deaths within the conflict. The Secretary-Gen-
eral’s 2015 report notes that the “total disregard for 
human life and dignity remains a defining feature 
of the Syrian conflict and continues on a daily basis 
with total impunity.”18 And despite agreements to 
establish de-escalation zones—and, more recently, 
a 30-day ceasefire, which would help ensure access 
to medicines—the guarantees have not been met.19 
International legal framework in times of 
conflict 
During times of conflict, there are essentially four 
bodies of international law that govern access to 
(essential) medicines. The first is international 
human rights law, which focuses on state respon-
sibility. The second is international drug control 
law, which regulates the availability of controlled 
medicines, including morphine for trauma care, 
palliative care, and pain control, which is partic-
ularly needed during armed conflict. The third is 
international humanitarian law, focusing mainly 
on state responsibility in times of war but also, to 
an extent, on the responsibility of non-state armed 
groups. The fourth is domestic and international 
criminal law, which focuses on individual criminal 
responsibility. 
All four legal frameworks are complemen-
tary and mutually reinforcing. International 
humanitarian law is often considered lex specialis, 
meaning that as a specialized area of law it would 
override more general law, such as international 
human rights law. Nevertheless, human rights law 
continues to apply in conflict situations. More-
over, international drug control law regulates the 
conditions on the basis of which governments can 
secure access to controlled medicines, also in times 
of conflict. 
International human rights law
International human rights law (IHRL) is the body 
of law designed to promote and protect human dig-
nity and the rights of individuals, largely vis-à-vis 
B. McGonigle Leyh and m. e. gispen / papers, 237-250
240
J U N E  2 0 1 8    V O L U M E  2 0    N U M B E R  1   Health and Human Rights Journal
state authorities. IHRL includes treaty-based and 
charter-based institutions that underpin the im-
portance of access to medicines in times of conflict. 
Access to medicines falls within the framework 
of various individual human rights, including, in 
some cases, the rights to life and to freedom from 
torture. However, within IHRL’s treaty-based sys-
tem, the right to the highest attainable standard of 
health—often referred to as the right to health—
provides for the most explicit framework on access 
to medicines. 
Article 12 of the International Covenant on 
Economic, Social and Cultural Rights (ICESCR) 
is the most elaborate provision on health within 
IHRL.20 On the basis of this article, states have 
obligations to prevent, treat, and control diseases 
and to create “conditions which would assure to all 
medical service and medical attention in the event 
of sickness.”21 The the provision of access to medi-
cines fits squarely into these obligations. Article 2 
of the covenant notes that obligations incumbent 
on states are obligations of both conduct and result, 
the latter of which are subject to progressive reali-
zation.22 The Committee on Economic, Social and 
Cultural Rights—which monitors compliance with 
the ICESCR—interprets the concept of progressive 
realization as requiring states to allocate their 
maximum available resources and to set specific 
targets and benchmarks to move as expeditiously 
as possible toward full realization of rights.23 At the 
same time, the committee acknowledges that some 
aspects of the right to health are considered so vital 
to protect the dignity and well-being of individuals 
that prolonging their realization would undermine 
the raison d’etre of the right to health itself.24 So-
called minimum core obligations and obligations 
of comparable priority therefore fall outside the 
scope of progressive realization and are subject to 
priority realization.25 
There are a range of arguments to make that 
ensuring access to medicines in times of conflict is 
part of a set of minimum core obligations of the right 
to health.26 This article singles out three grounds 
supporting the notion that ensuring access to med-
icines is part of a minimum core obligation subject 
to priority realization. First, according to the Com-
mittee on Economic, Social and Cultural Rights, 
the core obligation to ensure access to health facil-
ities, goods, and services includes ensuring access 
to medicines.27 Second, while access to medicines 
generally must be secured as a matter of priority 
under the right to health, those medicines that 
appear on the World Health Organization’s Model 
List of Essential Medicines should be available in 
all health systems.28 Morphine, as an important 
emergency and pain control medicine in times of 
conflict, appears on this list. The Committee on 
Economic, Social and Cultural Rights explicitly 
refers to essential medicines’ availability as a core 
obligation.29 Third, as part of their obligation of 
comparable priority to prevent, treat, and control 
diseases, states must create “a system of urgent 
medical care in cases of accidents … [to provide] 
humanitarian assistance in emergency situations.”30 
According to the Committee on Economic, 
Social and Cultural Rights, all health facilities, 
goods, and services, including medicines, should 
be available, accessible, acceptable, and of good 
quality. These criteria are often jointly referred to 
as the AAAQ standard of health care. In relation 
to access to medicines, this means that medicines 
should be available in sufficient quantities; physi-
cally available in health facilities within reasonable 
geographic distance to patients; affordable; cultur-
ally appropriate; and of sufficient evidence-based 
quality.31 The committee explains that “the precise 
application of [these criteria] will depend on the 
conditions prevailing in a particular State party.”32 
Since it is largely recognized that IHRL, in-
cluding the ICESCR, applies in times of conflict, and 
that ensuring access to medicines is part of the core 
of the right to health, the question is whether states 
may adopt retrogressive measures due to scarce 
resources or derogate from their obligations during 
temporary and exceptional circumstances, such as 
armed conflict.33 Article 2 of the ICESCR requires 
governments to progressively realize all rights in 
the covenant, including access to medicines as part 
of the right to health. As indicated in the Maastricht 
Guidelines on Violations of Economic, Social and 
Cultural Rights, governments are not allowed to 
adopt retrogressive measures aimed at deliberately 
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reducing the level of rights protections or chang-
ing public expenditures such that it would deprive 
people of at least minimum subsistence rights.34 
Retrogressive measures are allowed, however, when 
the progressive realization of a right is obstructed 
due to a permissible limitation (in light of the ICE-
SCR), force majeure, or lack of resources.35 That said, 
given the deterioration of health systems during 
conflict, it may be particularly difficult for states to 
ensure access to medicines as a matter of priority. 
The Committee on Economic, Social and Cultural 
Rights seems to accept armed conflict as a factor 
that influences the availability of resources, which 
may result in retrogressive measures.36 However, 
while article 2 of the ICESCR generally allows for 
the adoption of retrogressive measures, it is unlike-
ly that the committee would accept such measures 
“solely based on the existence of an armed conflict 
and the connected necessity to divert resources 
towards war efforts.”37 Indeed, the committee holds 
that any retrogressive measure that conflicts with 
the core obligations of the right to health results in 
a breach of the ICESCR.38 
In terms of limitations, legally most human 
rights may be limited; only a small selection of 
rights, such as freedom from torture, may not be 
limited or derogated from. Article 4 of the ICESCR 
includes the covenant’s general limitation clause, 
which states that any limitation of a right included 
in the covenant should be “compatible with the 
nature of these rights.”39 Given that minimum core 
obligations are meant to “prevent the nullification” 
of the rights included in the covenant, one could 
argue that such rights and obligations can never be 
limited on the basis of article 4.40 Indeed, article 4 
also reinforces the importance of minimum core 
obligations as minimum standards of protection 
that must be guaranteed at all times.
However, in the absence of a specific mention 
of conflict in articles 2 and 4, it remains somewhat 
ambiguous what role conflict or war has on the 
required minimum level of realization of the right 
to health.41 This is particularly acute in light of the 
AAAQ standard of health care that is set as a condi-
tion to the realization of the right to health. Despite 
this uncertainty, the Committee on Economic, 
Social and Cultural Rights generally emphasizes 
that those states that struggle or fail to effectively 
discharge their right to health obligations should 
seek financial and technical assistance from other 
countries and international bodies to work toward 
the full realization of the right to health, including 
in relation to medicine provision.42 Finally, unlike 
other human rights treaties, the ICESCR does not 
include a derogation clause. In the absence of such 
a clause, it is difficult to assess whether any degree 
of derogation would be allowed. Nevertheless, the 
committee explicitly recognizes the non-derogable 
nature of minimum core rights, which—as demon-
strated above—includes access to medicines.43 Only 
in extreme cases where “every effort has been made 
to use all the resources [at the disposal of the state] 
in an effort to satisfy, as a matter of priority, mini-
mum core obligations” could the state in question 
not be considered at fault.44
As for Syria, the government has ratified 
the ICESCR, as well as most other human rights 
treaties.45 The country was due for its fifth report-
ing cycle under the ICESCR in 2006. However, it 
has not submitted any reports since 1999.46 It does 
sporadically participate in the country reporting 
requirements of other treaty bodies, even during 
the conflict.47 Both the Committee against Torture 
and the Committee on the Elimination of Dis-
crimination against Women have urged the Syrian 
government to improve access to medical care and 
services. The Committee against Torture has called 
on the Syrian government to 
ensure that all acts in violation of the [Convention 
against Torture] are brought to a halt; and cease 
widespread, gross and continued human rights 
violations of all persons under its jurisdiction, 
especially systematic denial, in some areas, of the 
basic requirements of human life, such as food, 
water and medical care.48 
Similarly, the Committee on the Elimination of 
Discrimination against Women has urged Syria 
to “ensure that accountability mechanisms are in 
place in all displacement settings; and provide vic-
tims with immediate access to medical services.”49
Yet, none of the other UN treaty bodies have 
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specifically expressed outrage or called for com-
pliance or accountability on the topic of access 
to medicines or humanitarian assistance. Some 
observers argue that this silence is because Syria 
did not submit a country report—but regardless, 
such silence is particularly troubling coming 
from the Committee on Economic, Social and 
Cultural Rights since this committee monitors the 
implementation of the right to health. Even though 
treaty bodies’ general comments include sections 
on humanitarian assistance, the complexity of 
rights realization, particularly in the area of health, 
deserves more focused and dedicated attention 
within human rights law and international law in 
general. 
Within IHRL’s charter-based system, the UN 
Security Council, General Assembly, and Human 
Rights Council play the predominant roles in over-
seeing state compliance with human rights norms 
and obligations. In 2006, the Human Rights Coun-
cil adopted the Universal Period Review procedure, 
which is a process in which a troika of countries 
assesses the level of human rights protection in a 
given country. The process involves state reporting, 
questions, and input from the Office of the United 
Nations High Commissioner for Human Rights and 
civil society organizations. Within this Universal 
Periodic Review system, states have called on Syria 
to comply with its international legal obligations. 
For instance, Switzerland urged Syria to allow for 
unimpeded access to medical care, specifically am-
bulances and medical teams.50 
The Human Rights Council also has the ability 
to hold special sessions on situations of immediate 
importance that lead to widespread human rights 
violations. It has done so five times to discuss the 
situation in Syria.51 In four of these sessions and 
in three resulting resolutions, the council raised 
serious concerns about hindering access to medical 
treatment, blocking the safe passage of medical 
supplies, and attacks on health facilities and per-
sonnel. While reference to medical supplies is 
important, explicit reference to access to essential 
medicines would better reinforce the fact that ac-
cess to medicines is considered a core aspect of the 
right to heath. 
Other UN charter-based bodies have also 
produced important reports on health issues in 
Syria—and some, including the Independent In-
ternational Commission of Inquiry on the Syrian 
Arab Republic, have addressed the issues in a more 
comprehensive manner.52 For example, the com-
mission has urged the Syrian government to
end attacks against humanitarian workers, 
including medical personnel and first responders, 
and safeguard the sanctity of hospitals and 
medical transport … [and] … allow rapid, safe, 
sustained, unhindered and unconditional access 
to humanitarian aid, particularly to besieged and 
hard-to-reach areas.53
Additional IHRL actors, including the UN Special 
Rapporteur on the right to health, have also spoken 
out. In August 2016, Dainius Pūras urged all parties 
to the Syrian conflict to allow unimpeded access 
to humanitarian relief and to protect the rights 
of those in besieged and difficult-to-reach areas.54 
Such statements are welcome, but concrete declara-
tions of state obligations from a treaty monitoring 
body would carry more weight because of the legal 
obligations attached to the UN treaty body system. 
Overall, the compliance and accountability mecha-
nisms within IHRL, however, are not very powerful 
in turning around the health and human rights 
violations in a multiplayer seven-year conflict. 
International drug control law
International drug control law (IDCL) is the field of 
law that regulates the production, import, export, 
trade, distribution, and use of harmful substances 
such as psychotropic and narcotic drugs. Some 
of the medicines on the World Health Organiza-
tion’s Model List of Essential Medicines, such as 
morphine, are controlled medicines.55 Controlled 
medicines are medicines whose active pharma-
ceutical ingredient falls within the scope of IDCL, 
because of its serious abuse potential.
The 1961 Single Convention on Narcotic Drugs 
regulates the use of morphine for both trauma care 
and pain control and palliative care.56 Article 4 of 
the convention sets out a strict prohibition clause: 
all production, import, export, trade, distribution, 
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and use of controlled substances is forbidden ex-
cept if they are—simply put—produced and used 
to serve medical and scientific purposes. Medicines 
for both emergency care and pain control in conflict 
settings fall within this limitation clause. Articles 
17, 19, 20, and 30 set up an advanced licensing and 
monitoring system that states must adhere to in 
order to ensure access to medicines under IDCL. 
On the basis of these articles, states have to manage 
a separate administration (art. 17), submit annual 
overviews reflecting the country’s estimated need 
of controlled substances for medical and scientif-
ic purposes in the following year (art. 19), submit 
quarterly statistical returns to account for the use 
of the same substances (art. 20), and adopt specific 
trade and distribution requirements. The Interna-
tional Narcotics Control Board is responsible for 
monitoring implementation of these articles and 
issuing trade licenses on the basis of the estimates 
submitted. 
Adequate compliance with the licensing 
and monitoring system implies that states have 
smooth and well-functioning bureaucracies and 
health systems and that they have due insight in 
their country-specific epidemiology.57 The avail-
able guidelines also demonstrate that a high level 
of capacity is a conditio sine qua non for effective 
compliance.58 Countries with large remote areas 
or seriously constrained health systems—in terms 
of staff and finances—are put in a structurally 
disadvantaged position to implement and comply 
with these procedures.59 This results in countries 
either refraining from submitting estimates or 
including insufficient consumption figures in their 
estimates, which means that consumption will be 
inadequate.60 
While there is no provision in the SCND that 
discharges states of their drug control obligations 
in times of conflict, the International Narcotics 
Control Board manages simplified procedures 
in emergency situations. And in 1996, the World 
Health Organization adopted model guidelines 
for the international provision of controlled med-
icines for emergency care. Both the International 
Narcotics Control Board and the World Health 
Organization acknowledge that this issue is often 
complex, especially if domestic control authorities, 
who have to report to the International Narcotics 
Control Board, are malfunctioning due to, among 
other things, conflict.61 The simplified procedures 
reflect a practical solution to support access to 
controlled medicines for humanitarian assistance 
whereby suppliers can bypass control authorities in 
the receiving countries if unavailable, which partly 
reduces the administration involved. These simpli-
fied procedures are in place “when an emergency 
occurs which results in a disruption of the function 
of such authorities to issue import authoriza-
tions.”62 In other words, only if the Syrian control 
authorities are no longer capable of fulfilling their 
control mandate will the simplified procedures 
apply. If, on first sight—despite a conflict situa-
tion—the responsible institution remains capable 
of fulfilling its obligations, the standard rules seem 
to apply, which carries the same structural com-
plexities as mentioned before. The result may be 
that governments formally comply with the IDCL 
system because they submit the necessary paper-
work but the consumption prognosis included in 
the estimate may be insufficient to the extent that 
it is inadequate to treat the country’s absolute need 
of controlled medicines. This substantive gap seems 
apparent in the case of Syria.
Syria submits estimates to the International 
Narcotics Control Board, including a quantification of 
morphine, to give effect to its obligations under IDCL.63 
Yet, according to a 2014 study, Syria’s morphine con-
sumption figures remain far below par, reflecting only a 
5.16% adequacy of consumption.64 It is unclear whether 
organizations in Syria are supported by the Syrian 
government to make use of the simplified procedures 
because of its current conflict status.
Even though the International Narcotics 
Control Board flags the importance of access to 
emergency care in times of conflict and refers to 
the simplified procedures that it has adopted, it 
can do more. It calls upon governments to make 
use of these procedures, and its 2014 report even 
devotes a special section to the topic.65 However, 
when assessing the particular concerns in Syria in 
this same report, the board stresses only that the 
conflict in Syria is dangerous in terms of illicit drug 
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trafficking. It does not stress the importance of the 
simplified procedures in this context, despite the in-
adequate medical use of morphine in the country.66 
One may wonder whether the Syrian government is 
indeed effectively capable of fulfilling its reporting 
and administrative tasks under IDCL. Hence, the 
role of the International Narcotics Control Board 
in fostering access to medicines for emergency 
care should not just focus on either the simplified 
procedures in absence of a functioning competent 
authority or the application of the regular rules, 
but rather embrace an integrated approach and 
address the aggravated structural complexities 
that governments face when estimating need in 
conflict situations. In doing so, the board should 
take notice of the human rights standards on ac-
cess to medicines and take an integrated approach 
in monitoring progress. Instead, the currently 
fragmented discussion reflects a priority on law 
enforcement and control procedures within IDCL 
over access-to-medicine approaches. The IDCL 
system is frequently criticized for a one-sided and 
ineffective focus on harsh law enforcement. As was 
also concluded in a special edition of this journal 
on human rights and drug control, human rights 
are currently not adequately used to guide drug 
control efforts.67 The critical health situation in Syr-
ia reflects the devastating effect that this one-sided 
approach has on adequate standards of health care 
provision, including access to medicines.
International humanitarian law
International humanitarian law (IHL) is the law 
that regulates the conduct of armed conflict.68 It 
seeks to limit the effects of war by protecting per-
sons who are not participating in hostilities and by 
regulating and restricting the means and methods 
of warfare.69 Unlike IHRL, IHL does not protect 
individuals based solely on the notion of “inherent 
dignity.” Rather, it protects different “statuses,” 
including civilian, medical personnel, combatants, 
and persons hors de combat, within a pragmatic 
legal framework that balances the principle of hu-
manity with the principle of military necessity.70 
The two primary sources of IHL are treaty 
law and custom.71 With regard to treaty law, IHL 
consists of the four Geneva Conventions and Ad-
ditional Protocols I and II. IHL is generally divided 
between laws that apply to international armed 
conflicts and laws that apply to non-international 
armed conflicts, and it binds states and non-state 
armed groups. 
With regard to international conflicts, the 
provisions of humanitarian assistance—including, 
for example, access to medicine and the protection 
of medical personnel—can be found in Geneva 
Convention IV and Additional Protocol I.72 During 
non-international conflicts, the provisions of 
humanitarian assistance can likewise be found 
in common article 3 of the Geneva Conventions 
and Additional Protocol II (which Syria has not 
ratified).73 The laws impose an obligation on the 
parties, whether the state or non-state armed group, 
to ensure access to necessary medical supplies for 
the civilian population. Generally, and certainly 
in the case of Syria, this would include medicines 
such as pain control medication. While Additional 
Protocols I and II require the consent of the parties 
concerned for relief actions, including medicine 
provision, to take place, such consent must not be 
refused on arbitrary grounds, and the parties may 
operate control over the relief provided.74 
The most authoritative source on customary 
IHL is the study carried out by the International 
Committee of the Red Cross on the topic.75 The 
committee recognizes that access to humanitar-
ian relief for civilians in need, including medical 
supplies, is a recognized rule of customary IHL 
in international and non-international conflicts.76 
With regard to state practice, the obligation to al-
low and facilitate access to humanitarian relief for 
civilians in need, including access to medicines, 
is supported by official statements and actions by 
states and the UN.77 
Therefore, regardless of the legal characteriza-
tion of the conflict, IHL provides a legal framework 
obliging states and armed groups, under both 
customary and treaty law, to ensure humanitarian 
assistance and access to medicines.78 It usually falls 
to the authority exercising control over persons or 
territory to ensure that IHL norms and standards 
related to humanitarian relief are adhered to.79 
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And, as with IHRL, when states or non-state armed 
groups fail in these obligations, the international 
community responds politically and otherwise.
In terms of the current practical potential of 
IHL to address the access-to-medicine problem in 
Syria, the UN Security Council has passed a number 
of resolutions guaranteeing access to humanitarian 
assistance, including medical and surgical supplies, 
and hence medicines.80 The World Health Organi-
zation, UNICEF, International Committee of the 
Red Cross, and others are actively trying to deliver 
medical aid and provide access to medicines. How-
ever, for years, the Syrian government, coupled 
with the bombings carried out by Russia, continues 
to hinder the process. The UN Security Council 
has been made largely ineffective because of Rus-
sia’s veto power. For a long time, this veto power 
blocked any attempt to implement no-fly zones, 
which could have significantly lessoned civilian 
deaths and provided greater access to medicines. In 
terms of keeping pressure on Syria to comply with 
its IHL obligations, one response has been to better 
document the crimes and look toward a possible 
future prosecution, either domestically or inter-
nationally, for violations of war crimes or crimes 
against humanity. 
International criminal law and documentation 
of crimes
International criminal law is the body of law pro-
hibiting certain categories of conduct commonly 
viewed as serious atrocities and holding perpetra-
tors of such conduct criminally accountable for 
their acts. The core categories of crimes falling un-
der the jurisdiction of international criminal courts 
include war crimes, crimes against humanity, and 
genocide.81 While the International Criminal Court 
(ICC) was established to investigate and prosecute 
these crimes, it has only complementary jurisdic-
tion, meaning that states are primarily responsible 
for prosecuting such crimes. 
The ICC’s governing provisions provide a sol-
id framework for the criminalization of war crimes 
related to access to medicines, and many national 
jurisdictions have adopted similar provisions. There 
are a number of provisions of the Rome Statute of 
the ICC that could apply to violations of access 
to medicines. The first is article 8(2)(a)(iii), which 
criminalizes the willful causing of great suffering 
or serious injury to body or health. The second is 
article 8(2)(b) and (e), which deals with intention-
ally directing attacks against civilians, civilian 
objects, hospitals, medical units, and medical staff. 
Likewise, with regard to crimes against humanity, 
the crimes of extermination and persecution could 
be used to prosecute individuals for intentionally 
depriving individuals of medicine or humanitarian 
assistance.82
There are therefore, in theory, a number of 
avenues for perusing individual accountability 
for violations of access to medicines, either under 
the Rome Statute of the ICC or in domestic crim-
inal systems that may have jurisdiction over the 
crimes. However, there are also serious limitations. 
Bringing an individual before the ICC is not an 
easy process. The ICC prosecutor can begin an 
investigation only when the court has jurisdiction, 
including temporal, subject-matter, and territorial 
or personal jurisdiction. In fact, the ICC has ju-
risdiction only over alleged crimes committed on 
the territory of state parties, or by nationals of state 
parties, and Syria is not a state party to the Rome 
Statute of the ICC.83 Alternatively, the court may 
also obtain jurisdiction over a situation by a refer-
ral from the UN Security Council (which has been 
blocked by Russia), or by a declaration to the court 
by a non-state party (which Syria is unlikely to 
do).84 Moreover, even when jurisdiction exists, the 
challenges associated with an international prose-
cution are great. As a result, only a limited number 
of cases have been pursued to date, covering a small 
number of jurisdictions around the world. While 
pursuing domestic prosecutions for war crimes or 
crimes against humanity are an option, such pros-
ecutions would require a state to have criminalized 
these acts under national legislation, to have juris-
diction over the alleged perpetrator, and to have the 
political will to prosecute the cases. 
Yet, pressure is growing for some form of indi-
vidual accountability for serious human rights and 
humanitarian law violations. Prosecutions would 
draw much-needed attention to violations of the 
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right to health—particularly access to medicines—
and would provide some form of justice to victims. 
In response to the inability of the UN Security 
Council to take action, in late 2016, the General 
Assembly passed a resolution establishing the Inter-
national, Impartial and Independent Mechanism to 
Assist in the Investigation and Prosecution of Those 
Responsible for the Most Serious Crimes in Syria.85 
This mechanism is mandated to collect, consolidate, 
investigate, and analyze information about crimes in 
Syria and to build a case file for prosecution.86 The 
idea is to then share this information with national, 
regional, or international courts or tribunals that 
could exercise jurisdiction. It is the first such mecha-
nism of its kind and, if successful, may pave the way 
for others like it. It will be important for the new 
head of the mechanism, Catherine Marchi-Uhel, to 
focus on collecting information related to violations 
of access to medicines.
Complementary frameworks: Looking 
ahead
Within this complex picture of complementary le-
gal frameworks, there are a number of things being 
done for the situation in Syria. Yet, none have been 
able to ensure compliance or provide accountabili-
ty for violations of access to medicines. While this 
may simply reflect the inherent limitations of law 
generally, after reflecting on the complementarity 
of the legal frameworks discussed, looking ahead 
leads to a dual conclusion.
First, all four bodies of law discussed hold clear 
potential in terms of regulatory and accountability 
mechanisms for improving access to medicines in 
times of conflict, but they are too weak on their own 
account. The field of IHRL is strong in standard 
setting and identifying corresponding fundamen-
tal rights and obligations but lacks a powerful set of 
legal accountability measures. It needs to strength-
en its existing institutions and make specific and 
unified points on access to medicines in times of 
conflict in its treaty monitoring system. The IDCL 
framework should be used to simplify and foster 
access to medicines in emergency situations on the 
ground. International actors such as the Interna-
tional Narcotics Control Board should continue to 
actively promote the use of these simplified proce-
dures.87 And, at the same time, the board should 
take an integrated approach and focus on the 
structural challenges governments face, particu-
larly in conflict situations. These challenges often 
hamper their ability to comply with the general 
rules in IDCL. Finally, there is a strong emphasis 
on violations of the right to access medicines and 
medical/relief supplies within the IHL framework, 
but it too lacks direct accountability structures. In-
stead, accountability processes fall within domestic 
criminal processes or the ICL framework, and as 
shown above, the limitations are clear. The failures 
of these legal frameworks in terms of compliance 
and accountability highlight the limits of law op-
erating in highly volatile political environments. 
And while a legal framework, or a combination of 
legal frameworks, is clearly not going to solve the 
crisis in Syria, there are important steps that can 
be taken to strengthen these frameworks to better 
ensure compliance and accountability.
Second, the potential for on-the-ground 
change lies in the mutual reinforcement of the legal 
frameworks discussed. However, this reinforcement 
remains rhetorical and far from practical. There is 
too little synergy or “spillover effect” between these 
bodies of law, and international institutions should 
actively reach out to one another to strengthen the 
applicable law on access to medicine provision in 
times of conflict. They should also work toward a 
holistic interpretation and practical application of 
these four bodies of law in order to support better 
access to medicines in times of conflict and hold 
those accountable who are responsible for unlaw-
fully obstructing this access. The newly established 
International, Impartial and Independent Mecha-
nism to Assist in the Investigation and Prosecution 
of Those Responsible for the Most Serious Crimes 
in Syria offers some hope in this regard—but only 
if greater attention is paid to this topic when build-
ing individual case files. Moreover, both IHRL and 
IDCL should also mutually reinforce each other by, 
for example, the Committee on Economic, Social 
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and Cultural Rights and International Narcotics 
Control Board issuing a joint general comment on 
the issue. Within IHRL, humanitarian assistance 
is a crosscutting element of general comments; 
however, the case of Syria demonstrates that the 
complexity of health service delivery in times of 
conflict needs to be addressed at a more holistic 
level. Although specifically aimed at state account-
ability, these bodies of law should meanwhile pave 
the way for humanitarian organizations to deliver 
on-the-ground care, which requires, for instance, 
that the International Narcotics Control Board bet-
ter and actively promote the use of the simplified 
procedures.
Overall, attention to access to medicines 
must remain a priority within all compliance 
and accountability processes and legal frame-
works. The international community must act to 
strengthen these legal frameworks in response to 
the failures experienced thus far. The promotion 
of greater linkages between the health sector and 
legal and political environments, as well as great-
er collaboration between the various fields and 
legal frameworks are crucial starting points. The 
civilians in Syria who have been denied access to 
medicines deserve better protection. 
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